ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS


Industry
Biotechnology






 Company News
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged 3/2/2015 11:22:19 AM
Teva Pharmaceutical Industries (TEVA) Announces Early Results Of Debt Tender Offer, Pricing, Election Of Early Settlement And Increase In Maximum Amount And Priority 2 Notes Tender Cap 2/27/2015 8:28:52 AM
Teva Pharmaceutical Industries (TEVA) To Present At The Cowen and Company 35th Annual Healthcare Conference 2/26/2015 12:29:07 PM
Teva Pharmaceutical Industries (TEVA) Announces FDA Acceptance For Review Of NDA For Its Investigational Twice-Daily Hydrocodone Bitartrate Extended-Release Tablets With Proprietary Abuse Deterrence Technology 2/25/2015 10:36:08 AM
Teva Pharmaceutical Industries (TEVA) Release: The Lancet Respiratory Medicine And AAAAI Publish Positive Data From Phase 3 Trials Of Teva’s Reslizumab For The Treatment Of Moderate To Severe Asthma In Patients With Elevated Blood Eosinophils 2/24/2015 11:46:40 AM
Teva Pharmaceutical Industries (TEVA) Announces Positive Results For TEV-48125 In Phase IIb Chronic Migraine Study Meeting Primary And Secondary Endpoints 2/24/2015 11:24:10 AM
Teva Pharmaceutical Industries (TEVA) To Present New Respiratory Data At 2015 Annual Meeting Of The American Academy Of Allergy, Asthma And Immunology 2/20/2015 11:17:05 AM
Xenon Pharmaceuticals Inc. Partner Teva Pharmaceutical Industries (TEVA) To Initiate Phase 2b Clinical Trial Of TV-45070 In Post-Herpetic Neuralgia 2/20/2015 7:13:19 AM
Eagle Pharmaceuticals (EGRX) To Hold Conference Call At 8:30 A.M. EST Today To Discuss Licensing Agreement With Teva Pharmaceutical Industries (TEVA) To Commercialize Eagle’s Rapid Infusion Bendamustine 2/17/2015 11:16:49 AM
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015 10:43:31 AM
12345678910...